Cargando…
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164333/ https://www.ncbi.nlm.nih.gov/pubmed/32303915 http://dx.doi.org/10.1007/s40264-020-00935-2 |
| _version_ | 1783523271953612800 |
|---|---|
| author | Trifirò, Gianluca Crisafulli, Salvatore Andò, Giuseppe Racagni, Giorgio Drago, Filippo |
| author_facet | Trifirò, Gianluca Crisafulli, Salvatore Andò, Giuseppe Racagni, Giorgio Drago, Filippo |
| author_sort | Trifirò, Gianluca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7164333 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71643332020-04-17 Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? Trifirò, Gianluca Crisafulli, Salvatore Andò, Giuseppe Racagni, Giorgio Drago, Filippo Drug Saf Editorial Springer International Publishing 2020-04-17 2020 /pmc/articles/PMC7164333/ /pubmed/32303915 http://dx.doi.org/10.1007/s40264-020-00935-2 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Editorial Trifirò, Gianluca Crisafulli, Salvatore Andò, Giuseppe Racagni, Giorgio Drago, Filippo Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? |
| title | Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? |
| title_full | Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? |
| title_fullStr | Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? |
| title_full_unstemmed | Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? |
| title_short | Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? |
| title_sort | should patients receiving ace inhibitors or angiotensin receptor blockers be switched to other antihypertensive drugs to prevent or improve prognosis of novel coronavirus disease 2019 (covid-19)? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164333/ https://www.ncbi.nlm.nih.gov/pubmed/32303915 http://dx.doi.org/10.1007/s40264-020-00935-2 |
| work_keys_str_mv | AT trifirogianluca shouldpatientsreceivingaceinhibitorsorangiotensinreceptorblockersbeswitchedtootherantihypertensivedrugstopreventorimproveprognosisofnovelcoronavirusdisease2019covid19 AT crisafullisalvatore shouldpatientsreceivingaceinhibitorsorangiotensinreceptorblockersbeswitchedtootherantihypertensivedrugstopreventorimproveprognosisofnovelcoronavirusdisease2019covid19 AT andogiuseppe shouldpatientsreceivingaceinhibitorsorangiotensinreceptorblockersbeswitchedtootherantihypertensivedrugstopreventorimproveprognosisofnovelcoronavirusdisease2019covid19 AT racagnigiorgio shouldpatientsreceivingaceinhibitorsorangiotensinreceptorblockersbeswitchedtootherantihypertensivedrugstopreventorimproveprognosisofnovelcoronavirusdisease2019covid19 AT dragofilippo shouldpatientsreceivingaceinhibitorsorangiotensinreceptorblockersbeswitchedtootherantihypertensivedrugstopreventorimproveprognosisofnovelcoronavirusdisease2019covid19 AT shouldpatientsreceivingaceinhibitorsorangiotensinreceptorblockersbeswitchedtootherantihypertensivedrugstopreventorimproveprognosisofnovelcoronavirusdisease2019covid19 |